Cardiovascular Risk Factors in Patients with Valvular Heart Disease: A Nationwide Observational Cohort Study

Qianhong Lu1,2, Junxing Lv1,2,3,4, Zhe Li1,2

  • 1Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, People's Republic of China.

Insights

Conventional cardiovascular risk factors increase the risk of adverse outcomes in patients with valvular heart disease (VHD), particularly mitral regurgitation. Managing these risk factors is crucial for improving patient prognosis and secondary prevention strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Valvular heart disease (VHD) is a significant cardiovascular condition.
  • Conventional cardiovascular risk factors are increasingly recognized as potential contributors to VHD development and progression.

Purpose of the Study:

  • To investigate the prevalence of modifiable cardiovascular risk factors (smoking, hypertension, hyperlipidemia, diabetes) in patients with VHD.
  • To assess the impact of these risk factors on patient outcomes.
  • To identify prognostic indicators in VHD patients with varying risk factor burdens.

Main Methods:

  • A cohort study involving 11,862 patients with moderate or greater VHD.
  • Primary outcome: a composite of all-cause mortality, heart failure hospitalization, and myocardial infarction within two years.
  • Analysis of risk factor distribution and their association with outcomes, stratified by VHD type and etiology.

Main Results:

  • The study included 11,862 patients with VHD, with a mean age of 61.77 years and 44.4% females.
  • Prevalence of risk factors: hypertension (45.0%), smoking (14.9%), diabetes (14.5%), and hyperlipidemia (13.4%).
  • An increasing number of risk factors was independently associated with poorer two-year outcomes in patients with mitral regurgitation (MR), with a 17.3% higher risk of adverse events per additional risk factor in secondary MR. Females with three or four risk factors had poorer outcomes than males.

Conclusions:

  • Over 20% of VHD patients had at least two conventional cardiovascular risk factors.
  • The number of risk factors is a significant indicator of poor prognosis in patients with significant MR.
  • Optimizing the management of cardiovascular risk factors is essential for improving secondary prevention and long-term outcomes in VHD patients.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
2
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
4.3K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
2
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
2
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
102